Restart Life Sciences Corp. (NMLSF)
OTCMKTS · Delayed Price · Currency is USD
0.0679
-0.0261 (-27.77%)
Aug 8, 2025, 10:48 AM EDT
Inozyme Pharma Market Cap
Restart Life Sciences has a market cap or net worth of $2.62 million as of August 8, 2025. Its market cap has increased by 21.11% in one year.
Market Cap
2.62M
Enterprise Value
2.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since September 22, 2006, Restart Life Sciences's market cap has decreased from 3.94M to 2.62M, a decrease of -33.51%. That is a compound annual growth rate of -2.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 2.62M | 249.10% |
| Dec 31, 2024 | 751.10K | -66.30% |
| Dec 29, 2023 | 2.23M | -78.98% |
| Dec 30, 2022 | 10.60M | 118.83% |
| Dec 31, 2021 | 4.85M | -74.16% |
| Dec 31, 2020 | 18.75M | 278.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 366.75M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |